Andrea Phillips, M.C

NPI: 1558462382
Total Payments
$84,561
2024 Payments
$8,165
Companies
10
Transactions
150
Medicare Patients
1,390
Medicare Billing
$116,499

Payment Breakdown by Category

Consulting$50,858 (60.1%)
Travel$15,933 (18.8%)
Other$13,320 (15.8%)
Food & Beverage$4,417 (5.2%)
Education$32.27 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $50,858 23 60.1%
Travel and Lodging $15,933 51 18.8%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $9,750 6 11.5%
Food and Beverage $4,417 67 5.2%
Honoraria $3,570 2 4.2%
Education $32.27 1 0.0%

Top Paying Companies

Company Total Records Latest Year
E.R. Squibb & Sons, L.L.C. $30,085 25 $0 (2024)
PFIZER INC. $27,550 30 $0 (2024)
GlaxoSmithKline, LLC. $16,005 15 $0 (2020)
Merck Sharp & Dohme LLC $3,749 32 $0 (2024)
Alnylam Pharmaceuticals Inc. $3,215 15 $0 (2023)
Novartis Pharmaceuticals Corporation $2,708 25 $0 (2022)
Bayer HealthCare Pharmaceuticals Inc. $1,033 1 $0 (2020)
Lilly USA, LLC $93.60 5 $0 (2021)
ViiV Healthcare Company $90.00 1 $0 (2017)
Novo Nordisk Inc $32.27 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $8,165 23 PFIZER INC. ($4,981)
2023 $30,375 41 E.R. Squibb & Sons, L.L.C. ($20,499)
2022 $20,022 26 PFIZER INC. ($15,102)
2021 $3,967 6 E.R. Squibb & Sons, L.L.C. ($3,766)
2020 $17,319 19 GlaxoSmithKline, LLC. ($14,356)
2019 $1,779 7 GlaxoSmithKline, LLC. ($1,650)
2018 $207.53 3 PFIZER INC. ($112.65)
2017 $2,726 25 Novartis Pharmaceuticals Corporation ($2,600)

All Payment Transactions

150 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
10/30/2024 PFIZER INC. PAXLOVID (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,600.00 General
Category: INFECTIOUS DISEASES
09/26/2024 PFIZER INC. PAXLOVID (Drug) Travel and Lodging In-kind items and services $1,067.16 General
Category: INFECTIOUS DISEASES
09/26/2024 PFIZER INC. PAXLOVID (Drug) Travel and Lodging In-kind items and services $804.73 General
Category: INFECTIOUS DISEASES
09/26/2024 PFIZER INC. PAXLOVID (Drug) Travel and Lodging In-kind items and services $412.64 General
Category: INFECTIOUS DISEASES
09/25/2024 E.R. Squibb & Sons, L.L.C. Consulting Fee Cash or cash equivalent $1,520.00 General
09/17/2024 Merck Sharp & Dohme LLC Food and Beverage In-kind items and services $99.98 General
05/09/2024 Merck Sharp & Dohme LLC VERQUVO (Drug) Food and Beverage Cash or cash equivalent $23.62 General
Category: CARDIOVASCULAR
05/08/2024 Merck Sharp & Dohme LLC VERQUVO (Drug) Travel and Lodging In-kind items and services $236.17 General
Category: CARDIOVASCULAR
05/08/2024 Merck Sharp & Dohme LLC VERQUVO (Drug) Food and Beverage In-kind items and services $64.94 General
Category: CARDIOVASCULAR
05/08/2024 Merck Sharp & Dohme LLC VERQUVO (Drug) Food and Beverage In-kind items and services $59.98 General
Category: CARDIOVASCULAR
05/08/2024 Merck Sharp & Dohme LLC VERQUVO (Drug) Food and Beverage In-kind items and services $54.99 General
Category: CARDIOVASCULAR
05/08/2024 Merck Sharp & Dohme LLC VERQUVO (Drug) Food and Beverage Cash or cash equivalent $50.80 General
Category: CARDIOVASCULAR
05/07/2024 Merck Sharp & Dohme LLC VERQUVO (Drug) Travel and Lodging In-kind items and services $403.96 General
Category: CARDIOVASCULAR
05/07/2024 Merck Sharp & Dohme LLC VERQUVO (Drug) Travel and Lodging In-kind items and services $236.17 General
Category: CARDIOVASCULAR
05/07/2024 Merck Sharp & Dohme LLC VERQUVO (Drug) Food and Beverage In-kind items and services $149.67 General
Category: CARDIOVASCULAR
05/07/2024 Merck Sharp & Dohme LLC VERQUVO (Drug) Travel and Lodging In-kind items and services $118.38 General
Category: CARDIOVASCULAR
05/07/2024 Merck Sharp & Dohme LLC VERQUVO (Drug) Travel and Lodging In-kind items and services $58.90 General
Category: CARDIOVASCULAR
05/07/2024 Merck Sharp & Dohme LLC VERQUVO (Drug) Food and Beverage Cash or cash equivalent $34.62 General
Category: CARDIOVASCULAR
05/07/2024 Merck Sharp & Dohme LLC VERQUVO (Drug) Travel and Lodging Cash or cash equivalent $23.99 General
Category: CARDIOVASCULAR
04/10/2024 PFIZER INC. Food and Beverage In-kind items and services $96.67 General
01/30/2024 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $23.75 General
01/30/2024 E.R. Squibb & Sons, L.L.C. Travel and Lodging Cash or cash equivalent $14.58 General
01/30/2024 E.R. Squibb & Sons, L.L.C. Travel and Lodging Cash or cash equivalent $9.17 General
12/15/2023 PFIZER INC. Food and Beverage In-kind items and services $51.35 General
12/08/2023 PFIZER INC. PAXLOVID (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,900.00 General
Category: INFECTIOUS DISEASES

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 224 597 $41,895 $22,831
2022 12 286 621 $51,439 $28,413
2021 16 506 807 $62,929 $35,920
2020 12 374 701 $63,893 $29,335
Total Patients
1,390
Total Services
2,726
Medicare Billing
$116,499
Procedure Codes
49

All Medicare Procedures & Services

49 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 34 127 $17,780 $10,109 56.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 28 85 $8,075 $4,693 58.1%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 30 62 $4,030 $2,143 53.2%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 18 18 $3,150 $2,111 67.0%
K1034 Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count Office 2023 27 137 $2,740 $1,611 58.8%
99497 Advance care planning, first 30 minutes Office 2023 20 20 $3,000 $1,179 39.3%
36415 Insertion of needle into vein for collection of blood sample Office 2023 32 72 $1,080 $604.80 56.0%
G0444 Annual depression screening, 5 to 15 minutes Office 2023 15 15 $1,125 $245.25 21.8%
81003 Automated urinalysis test Office 2023 20 61 $915.00 $134.20 14.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 39 186 $25,400 $15,052 59.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 30 86 $8,050 $5,160 64.1%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 22 22 $3,850 $2,643 68.6%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 24 45 $2,925 $1,839 62.9%
99497 Advance care planning, first 30 minutes Office 2022 24 24 $3,600 $876.00 24.3%
K1034 Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count Office 2022 13 66 $1,320 $778.92 59.0%
0134A Fee covid-19 vac 14 res Office 2022 22 22 $1,140 $767.14 67.3%
G0442 Annual alcohol misuse screening, 15 minutes Office 2022 20 20 $1,500 $335.94 22.4%
G0444 Annual depression screening, 15 minutes Office 2022 20 20 $1,500 $329.90 22.0%
G0008 Administration of influenza virus vaccine Office 2022 12 12 $384.00 $315.96 82.3%
36415 Insertion of needle into vein for collection of blood sample Office 2022 35 73 $1,095 $215.97 19.7%
81003 Automated urinalysis test Office 2022 25 45 $675.00 $99.99 14.8%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 44 202 $26,270 $16,345 62.2%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 38 79 $7,110 $4,562 64.2%
99212 Established patient outpatient visit, total time 10-19 minutes Office 2021 31 67 $4,355 $2,703 62.1%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2021 20 20 $3,500 $2,447 69.9%

About Andrea Phillips, M.C

Andrea Phillips, M.C is a Family Medicine healthcare provider based in Jackson, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558462382.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Andrea Phillips, M.C has received a total of $84,561 in payments from pharmaceutical and medical device companies, with $8,165 received in 2024. These payments were reported across 150 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($50,858).

As a Medicare-enrolled provider, Phillips has provided services to 1,390 Medicare beneficiaries, totaling 2,726 services with total Medicare billing of $116,499. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Jackson, MS
  • Active Since 09/26/2006
  • Last Updated 07/09/2007
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1558462382

Products in Payments

  • ELIQUIS (Drug) $18,265
  • PAXLOVID (Drug) $11,785
  • VERQUVO (Drug) $3,549
  • ENTRESTO (Drug) $1,589
  • Non-Covered $1,033
  • EMGALITY (Drug) $74.09
  • ZEPATIER (Drug) $35.66
  • Ozempic (Drug) $32.27
  • TRULICITY (Drug) $19.51
  • LEQVIO (Drug) $12.54

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Jackson